Clínica de Marly S.A. (BVC:MARLY)

Clínica de Marly Balance Sheet

Financials in millions COP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	35,427	47,072	36,328	45,907	33,319
Short-Term Investments	188,179	100,588	64,991	61,266	48,820
Cash & Short-Term Investments	223,606	147,660	101,319	107,173	82,139
Cash Growth	51.43%	45.74%	-5.46%	30.48%	47.22%
Accounts Receivable	106,148	113,115	100,580	76,537	59,306
Other Receivables	2,285	1,820	1,756	2,347	5,046
Receivables	108,433	115,225	102,578	78,884	64,353
Inventory	6,959	6,583	6,366	5,269	5,825
Other Current Assets	804.08	808.22	986.16	898.77	577.32
Total Current Assets	339,803	270,277	211,249	192,225	152,894
Property, Plant & Equipment	344,299	345,442	345,068	191,091	184,160
Long-Term Investments	2,195	3,685	3,663	3,691	1,506
Other Intangible Assets	784.79	840.33	1,328	1,963	986.7
Long-Term Deferred Tax Assets	5,537	4,399	3,487	4,342	6,885
Other Long-Term Assets	81,690	80,913	81,770	64,623	66,020
Total Assets	774,309	705,556	646,565	457,934	412,451
Accounts Payable	52,017	24,937	10,233	8,310	4,557
Accrued Expenses	24,654	17,791	23,552	16,249	13,507
Current Portion of Long-Term Debt	2,924	8,396	8,396	8,646	8,517
Current Portion of Leases	823.82	895.79	751.16	738.75	904.38
Current Income Taxes Payable	-	13,078	11,344	6,576	1,407
Current Unearned Revenue	677.77	11,165	12,409	10,903	13,693
Other Current Liabilities	-	9,114	6,923	10,150	9,490
Total Current Liabilities	81,096	85,376	73,608	61,573	52,075
Long-Term Debt	-	2,924	11,319	20,340	29,192
Long-Term Leases	2,649	1,089	1,850	2,523	3,311
Long-Term Deferred Tax Liabilities	50,692	52,355	51,897	15,748	17,234
Other Long-Term Liabilities	614.18	614.19	614.18	-	-
Total Liabilities	135,242	142,598	139,632	100,668	102,469
Common Stock	108.09	108.09	108.09	108.09	108.09
Additional Paid-In Capital	8,061	8,061	8,061	8,061	8,061
Retained Earnings	282,064	420,739	364,213	343,517	297,738
Comprehensive Income & Other	342,253	128,230	128,541	-	-
Total Common Equity	632,486	557,139	500,923	351,686	305,907
Minority Interest	6,580	5,819	6,010	5,580	4,075
Shareholders' Equity	639,067	562,958	506,933	357,266	309,982
Total Liabilities & Equity	774,309	705,556	646,565	457,934	412,451
Total Debt	6,396	13,304	22,317	32,248	41,924
Net Cash (Debt)	217,210	134,356	79,003	74,925	40,215
Net Cash Growth	61.67%	70.06%	5.44%	86.31%	169.09%
Net Cash Per Share	-	12582.56	7398.66	7016.82	3766.21
Filing Date Shares Outstanding	-	10.68	10.68	10.68	10.68
Total Common Shares Outstanding	-	10.68	10.68	10.68	10.68
Working Capital	258,707	184,900	137,641	130,652	100,818
Book Value Per Share	-	52176.56	46911.93	32935.74	28648.50
Tangible Book Value	631,702	556,299	499,595	349,724	304,921
Tangible Book Value Per Share	-	52097.87	46787.55	32751.95	28556.10
Land	-	136,071	136,071	40,192	40,192
Buildings	-	179,668	179,657	122,672	117,573
Machinery	-	61,420	57,990	48,174	39,422
Construction In Progress	-	4,141	1,480	988.08	2,202

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.